RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $206,000 | +21.2% | 69,105 | +7.6% | 0.00% | 0.0% |
| Q4 2021 | $170,000 | -56.4% | 64,251 | -40.3% | 0.00% | -60.0% |
| Q3 2021 | $390,000 | -1.3% | 107,539 | +18.1% | 0.01% | 0.0% |
| Q2 2021 | $395,000 | +70.3% | 91,073 | +34.3% | 0.01% | +25.0% |
| Q1 2021 | $232,000 | -50.7% | 67,808 | -49.7% | 0.00% | -60.0% |
| Q4 2020 | $471,000 | +175.4% | 134,746 | +88.6% | 0.01% | +150.0% |
| Q3 2020 | $171,000 | +62.9% | 71,457 | +24.0% | 0.00% | +33.3% |
| Q2 2020 | $105,000 | +14.1% | 57,644 | -2.6% | 0.00% | -25.0% |
| Q1 2020 | $92,000 | -18.6% | 59,186 | +11.8% | 0.00% | 0.0% |
| Q4 2019 | $113,000 | +11.9% | 52,931 | -2.1% | 0.00% | -20.0% |
| Q3 2019 | $101,000 | -73.0% | 54,071 | -62.3% | 0.01% | -76.2% |
| Q2 2019 | $374,000 | +12.3% | 143,502 | +10.7% | 0.02% | -4.5% |
| Q1 2019 | $333,000 | +28.1% | 129,671 | +14.6% | 0.02% | -15.4% |
| Q4 2018 | $260,000 | -14.2% | 113,123 | +19.6% | 0.03% | -10.3% |
| Q3 2018 | $303,000 | +32.9% | 94,599 | +17.3% | 0.03% | +11.5% |
| Q2 2018 | $228,000 | +16.9% | 80,630 | +45.8% | 0.03% | -3.7% |
| Q1 2018 | $195,000 | – | 55,299 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |